CCL21 and neoplasm: As our focus has been on TLS formation and tumor dysregulation of the chemokines and cytokines involved in their development, a cursory search of common transcriptional regulators of CCL19, CCL21, CXCL13 and LTA/B gene expression may provide insight into potential biomarkers for humoral anti-tumor immunity.